All Stories

  1. Midostaurin: a novel therapeutic agent for patients with FLT3-mutated acute myeloid leukemia and systemic mastocytosis

    Article • Therapeutic Advances in Hematology, August 2017, SAGE Publications

    Brenda Cooper